National Study for Prevention of Embolism in Atrial Fibrillation "NASPEAF"

Completed

Phase N/A Results

Summary of Purpose

To evaluate the efficacy and safety of the combination of antiplatelet and moderate-intensity anticoagulation therapy in patients with atrial fibrillation associated with recognized risk factors or mitral stenosis.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 10 May 2006.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Spanish Society of Cardiology (Madrid) and Uriach Foundation (Barcelona).

Trial Design

Prospective, multicenter, randomized open-label study.

Contacts

Not available